SIM
VYGR icon

Spark Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Spark Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.3K Buy
+13,500
New +$51.2K 0.09% 58
2019
Q2 		– Sell
-146,200
Closed -$2.8M – 711
2019
Q1 		$2.8M Buy
146,200
+22,800
+18% +$297K 0.13% 203
2018
Q4 		$1.16M Buy
+123,400
New +$1.58M 0.08% 292

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Spark Investment Management's VYGR Position: Q2 2026 in Review

Spark Investment Management opened a new position in Voyager Therapeutics (VYGR) in Q2 2026: 13,500 shares worth $47.3K. The stake represents 0.09% of the portfolio and ranks #58 among its holdings. This is a return to the name: Spark Investment Management previously reported a position in VYGR as recently as Q1 2019.

Spark Investment Management first reported a position in VYGR in Q4 2018 and has held it in 3 quarters since. The position peaked at $2.8M in Q1 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Spark Investment Management held 13,500 shares of Voyager Therapeutics worth $47.3K as of Q2 2026.
  • Voyager Therapeutics was a new Spark Investment Management position in Q2 2026.
  • Voyager Therapeutics made up 0.09% of Spark Investment Management's portfolio in Q2 2026, its #58 holding.
  • Spark Investment Management first reported a position in Voyager Therapeutics in Q4 2018 and has held it in 3 quarters since.
  • Spark Investment Management's Voyager Therapeutics position peaked at $2.8M in Q1 2019.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Spark Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.